A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome.

PHASE2UnknownINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

March 22, 2021

Primary Completion Date

April 30, 2022

Study Completion Date

June 30, 2022

Conditions
Primary Sjögren Syndrome
Interventions
DRUG

Iguratimod

Iguratimod orally twice a day

DRUG

Placebo

Placebo orally twice a day

Trial Locations (30)

100032

RECRUITING

Peking University People's Hospital, Beijing

130000

RECRUITING

Jilin Province People's Hospital, Changchun

250021

RECRUITING

Shandong Provincial Hospital Affliated to Shandong First Medical University, Jinan

314000

RECRUITING

The Second Affiliated Hospital of Jiaxing University, Jiaxing

315010

RECRUITING

Ningbo First Hospital, Ningbo

410000

RECRUITING

The Second Xiangya Hospital of Central South University, Changsha

510000

RECRUITING

Southern Medical University Nanfang Hospital, Guangzhou

RECRUITING

Sun Yat-sen Memorial Hospital, Guangzhou

Unknown

RECRUITING

The First Affiliated Hospital of Xiamen University, Xiamen

NOT_YET_RECRUITING

the Second Affiliated Hospital of Guangxi Medical University, Nanning

NOT_YET_RECRUITING

Hebei General Hospital, Shijiazhuang

RECRUITING

the Second Hospital of HeBei Medical University, Shijiazhuang

RECRUITING

the First Affiliated Hospital of Henan University of Science and Technology, Luoyang

NOT_YET_RECRUITING

Xinxiang Central Hospital, Xinxiang

RECRUITING

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

RECRUITING

Jiangsu Province Hospital, Nanjing

RECRUITING

Nanjing Drum Tower Hospital, Nanjing

NOT_YET_RECRUITING

the First Hospital of Jilin University, Changchun

NOT_YET_RECRUITING

Qilu Hospital of Shandong University, Jinan

NOT_YET_RECRUITING

the Shanghai Ninth People's Hospital, Shanghai

NOT_YET_RECRUITING

Tongji Hospital of Tongji University, Shanghai

RECRUITING

Heping Hospital Affiliated to Changzhi Medical College, Changzhi

NOT_YET_RECRUITING

Shanxi Bethune hospital, Taiyuan

NOT_YET_RECRUITING

the Second Hospital of Shanxi Medical University, Taiyuan

NOT_YET_RECRUITING

the Second Affiliated Hospital of Xi'an Jiaotong University, Xi’an

RECRUITING

Tianjin First Central Hospital, Tianjin

NOT_YET_RECRUITING

Zhejiang Provincial People's Hospital, Hangzhou

NOT_YET_RECRUITING

the First People's Hospital of Wenling, Wenling

RECRUITING

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou

010000

RECRUITING

The Affiliated Hospitalof Inner Mongolia Medical University, Hohhot

All Listed Sponsors
lead

Jiangsu Simcere Pharmaceutical Co., Ltd.

INDUSTRY